These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22456612)

  • 21. Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome.
    Llamas-Velasco M; Requena L; Kutzner H; Schärer L; Rütten A; Hantschke M; Paredes BE; Mentzel T
    J Cutan Pathol; 2014 Nov; 41(11):859-65. PubMed ID: 25292446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
    Varol A; Stapleton K; Roscioli T
    Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
    Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K
    Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase (FH) as pathogenic.
    Ouchene L; Wilde B; Chan-Pak-Choon F; Camacho Valenzuela J; Brimo F; Witkowski L; Christofk H; Domecq C; Fu L; Weber E; Lemieux Anglin B; Netchiporouk E; Foulkes WD
    Genes Chromosomes Cancer; 2024 Feb; 63(2):e23221. PubMed ID: 38682608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First Presentation of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Pregnancy.
    Woolner K; O'Toole A; LaBerge L
    J Cutan Med Surg; 2016 Jul; 20(4):334-6. PubMed ID: 26902252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
    Badeloe S; Frank J
    Eur J Dermatol; 2009; 19(6):545-51. PubMed ID: 19939761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary Leiomyomatosis and Renal Cell Cancer.
    Hansen AW; Chayed Z; Pallesen K; Codruta Vasilescu I; Bygum A
    Acta Derm Venereol; 2020 Jan; 100(1):adv00012. PubMed ID: 31663596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience.
    Rabban JT; Chan E; Mak J; Zaloudek C; Garg K
    Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
    Alam NA; Olpin S; Leigh IM
    Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
    Grubb RL; Franks ME; Toro J; Middelton L; Choyke L; Fowler S; Torres-Cabala C; Glenn GM; Choyke P; Merino MJ; Zbar B; Pinto PA; Srinivasan R; Coleman JA; Linehan WM
    J Urol; 2007 Jun; 177(6):2074-9; discussion 2079-80. PubMed ID: 17509289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous leiomyosarcoma in a case of hereditary leiomyomatosis and renal cell carcinoma syndrome.
    O'Connor M; Paul M; Wylie G
    BMJ Case Rep; 2024 Aug; 17(8):. PubMed ID: 39179269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review.
    Patel VM; Handler MZ; Schwartz RA; Lambert WC
    J Am Acad Dermatol; 2017 Jul; 77(1):149-158. PubMed ID: 28314682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary leiomyomatosis and renal cell cancer without cutaneous manifestations in two Japanese siblings.
    Noguchi G; Furuya M; Okubo Y; Nagashima Y; Kato I; Matsumoto K; Tanaka R; Hisasue SI; Yao M; Kishida T
    Int J Urol; 2018 Sep; 25(9):832-835. PubMed ID: 30058172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses.
    El-Zaatari Z; Divatia MK
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S7-S17. PubMed ID: 32108620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma.
    Skala SL; Dhanasekaran SM; Mehra R
    Arch Pathol Lab Med; 2018 Oct; 142(10):1202-1215. PubMed ID: 30281371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome.
    Breen KE; Carlo MI; Kemel Y; Maio A; Chen YB; Zhang L; Ceyhan-Birsoy O; Mandelker D
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1293. PubMed ID: 32463173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple cutaneous and uterine leiomyomatosis or reed syndrome: a retrospective study of 13 cases.
    Collgros H; Iglesias-Sancho M; Tribó-Boixareu MJ; Creus-Vila L; Umbert-Millet P; Salleras-Redonnet M
    Actas Dermosifiliogr; 2015 Mar; 106(2):117-25. PubMed ID: 25439147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and molecular characteristics of fumarate hydratase-deficient uterine smooth muscle tumors: a single-center study of 52 cases.
    Li H; Yang W; Tu X; Yu L; Huang D; Cheng Y; Chang B; Tang S; Ge H; Bao L; Zhou X; Bi R
    Hum Pathol; 2022 Aug; 126():136-145. PubMed ID: 35659509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
    Trpkov K; Hes O; Agaimy A; Bonert M; Martinek P; Magi-Galluzzi C; Kristiansen G; Lüders C; Nesi G; Compérat E; Sibony M; Berney DM; Mehra R; Brimo F; Hartmann A; Husain A; Frizzell N; Hills K; Maclean F; Srinivasan B; Gill AJ
    Am J Surg Pathol; 2016 Jul; 40(7):865-75. PubMed ID: 26900816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
    Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR
    Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.